Best Supplements to Take With GLOW

Three Pathways, One Requirement: Raw Materials

GLOW is not a single molecule with a single mechanism. It is three peptides working through three distinct biological routes simultaneously, and understanding what that means for supplementation requires looking at each one briefly.

GHK-Cu, the copper peptide component, carries copper ions into cells and activates the enzymes that cross-link collagen and elastin fibers into durable tissue. Think of collagen synthesis as a production line: GHK-Cu turns the line on and speeds it up. But the line needs specific inputs to produce anything. The enzyme that stitches collagen chains into their final stable structure cannot function at all without vitamin C. A second enzyme that cross-links those chains into strong connective tissue depends on copper. Run GHK-Cu without adequate vitamin C and copper, and the upregulated production produces structurally weak, unstable protein. The signal fires. The raw material is not there. The result is proportionally weaker.

BPC-157, the second component, works primarily by triggering the growth of new blood vessels into damaged tissue. New vasculature is how a repair site receives the oxygen, immune cells, and nutrients needed to complete healing. This process consumes iron at a meaningful rate: hemoglobin, the molecule that carries oxygen through those new vessels, requires iron to function. If iron stores are already marginal, the oxygen delivery that makes this new vasculature useful cannot keep up with the demand GLOW is creating.

TB-500, the third component, reorganizes the cellular scaffolding that cells use to move through tissue. When injury occurs, repair cells need to migrate to the site, lay down new matrix, and remodel existing structures. TB-500 facilitates that movement. It works in concert with BPC-157: new vessels bring repair cells in, and TB-500 ensures those cells can move where they need to go.

GLOW is categorically different from the GH secretagogues it sometimes gets grouped alongside. Compounds like ipamorelin or CJC-1295 drive pituitary growth hormone release, which elevates IGF-1 (a growth hormone that circulates through the whole body) systemically and promotes body-wide anabolic signaling. GLOW produces no meaningful IGF-1 elevation. Its effects are repair-directed and largely local. This matters for supplementation: the micronutrient and cofactor needs for local tissue repair are different from the protein and substrate needs for systemic anabolic signaling, and this stack reflects that.

It also differs from its closest relative in the blend family. KLOW adds a fourth peptide, KPV, which targets the melanocortin pathway to modulate inflammation through a direct receptor mechanism. GLOW's anti-inflammatory effects emerge from the repair process itself, not from receptor-level signaling, which means the inflammation GLOW manages is the downstream consequence of healing rather than a separate pharmacological target.

GLOW is typically run on a daily injection schedule, most commonly in the evening so that the post-injection nausea window falls during sleep. This daily cadence means cofactor and support supplements are best built into a consistent daily routine rather than timed specifically around the injection. The one exception is magnesium, which aligns naturally with evening dosing.

The gap this creates is predictable. A person running GLOW is asking the body to repair tissue faster than it naturally would, build collagen at an elevated rate, grow new vasculature, and remodel extracellular structures. All of that requires raw materials the peptide signal cannot supply. Vitamin C, copper, zinc, iron, vitamin D, magnesium, and the amino acid substrate for collagen synthesis are what GLOW is trying to consume more of. A body that is short on any of them produces a proportionally smaller result from a compound that costs real money and involves real injections.

The Supplements That Matter Most on GLOW

There are no dose numbers on this page because the right amount of each supplement depends on your actual protocol, your current bloodwork, and what else you are already taking. A person with low baseline ferritin needs a different iron conversation than someone with normal stores, and copper and zinc need to be managed together rather than as two independent numbers. The MyPeptidePal app works through your specific situation rather than printing a number that is correct for an average and wrong for most individuals.

What the Body Cannot Build Collagen Without

Vitamin C

Collagen is assembled from individual chains of amino acids, but those chains must be chemically modified before they can twist together into the stable, durable structure that makes tendons and skin actually hold together. The enzyme responsible for that modification, the one that chemically modifies the building blocks of collagen so they can lock together into a stable structure, is completely dependent on vitamin C. Remove the vitamin C and the enzyme stops. The collagen chains are produced, because GHK-Cu has upregulated their transcription, but they cannot form the structure that gives collagen its mechanical properties. The result is structurally compromised tissue.

This is a rate-limiting relationship, not a general health principle. Vitamin C is not included here because it is broadly beneficial. It is included because the specific biochemical step that turns GLOW's collagen signal into real collagen cannot proceed without it. The relationship has been established clearly in human biochemistry, and it holds regardless of which signaling pathway initiates the collagen synthesis.

Vitamin C carries a second function relevant to GLOW. It recycles glutathione, the body's primary antioxidant molecule, from its used-up form back to its active form. GHK-Cu has documented antioxidant properties, and those properties depend partly on the glutathione system remaining operational. A reader getting a large antioxidant benefit from GHK-Cu but running consistently low on vitamin C is not getting the full picture.

Vitamin C is water-soluble and the body clears it continuously. Split dosing across morning and evening supports more consistent tissue-level availability throughout the day, which matters for a compound running a daily repair signal. This is also a double-duty supplement: it enables the collagen modification step on the cofactor lever, and it enhances non-heme iron absorption, which matters directly given what GLOW does to ferritin over a cycle.

Zinc

Zinc sits at the intersection of wound healing and collagen remodeling. The enzymes that build collagen matrix, support immune function at the repair site, and facilitate the controlled breakdown of damaged tissue during remodeling all require zinc to activate. Deficiency here is not rare: zinc is lost during active healing, and people running repair-focused peptides are running elevated levels of the exact processes that deplete it.

The critical constraint for GLOW specifically is the zinc-copper relationship. Zinc and copper compete for the same intestinal transport proteins. At standard physiological amounts, zinc complements the stack. At doses well above the physiological range, zinc begins to meaningfully deplete copper, and copper is the metal at the center of GHK-Cu's mechanism. The copper peptide delivers copper to activate enzymes. If zinc supplementation is simultaneously stripping copper from circulation, the two inputs are working in opposite directions.

Keeping zinc within the physiological range is not optional on GLOW. It is how the stack avoids working against itself. This interaction is covered in the cautions section because at high doses it becomes a serious concern rather than a minor note, but the practical implication is simple: standard amounts are appropriate and beneficial; excess is counterproductive.

Fix These Before You Blame the Peptide

Iron

If there is one deficiency that caps GLOW results more reliably than any other, it is low ferritin. Ferritin is the protein that stores iron in the body, and its level is the most informative single indicator of iron status for this purpose.

GLOW creates downward pressure on ferritin through two distinct mechanisms. The first is straightforward: active tissue remodeling, new blood vessel formation, and extracellular matrix reconstruction all consume iron as a metabolic substrate. Building new blood vessels requires hemoglobin, and hemoglobin is an iron-containing protein. The body is doing more of this than it would without the peptide, and the demand for iron rises accordingly.

The second mechanism is subtler. Ferritin is an acute-phase reactant, meaning it rises when the body is inflamed and falls when inflammation resolves. BPC-157 and TB-500 both have documented anti-inflammatory properties as part of their healing mechanism. As GLOW reduces systemic inflammation during a cycle, ferritin can fall as a consequence of that reduction, mimicking iron depletion on a blood test. A falling ferritin during a GLOW cycle requires a full iron panel, including serum iron, transferrin saturation, and total iron-binding capacity. That panel distinguishes whether the body actually needs more iron or whether the drop reflects inflammation normalizing.

The practical consequence of genuinely low ferritin is straightforward: oxygen delivery to the tissue being repaired slows. The new blood vessels BPC-157 promotes carry oxygen only if there is adequate hemoglobin to load. Iron deficiency puts a ceiling on the repair process regardless of how effectively the peptide is signaling.

Iron bisglycinate is better tolerated than other forms. Taking it alongside vitamin C measurably enhances absorption. Separating it from zinc and calcium by at least two hours prevents competitive absorption from reducing how much actually gets through.

Vitamin D

Vitamin D earns its place on this stack not as a general wellness supplement but because of a specific functional role: it is required for gut iron absorption. The intestinal cells that take up iron from food and supplements need vitamin D to function properly in this capacity. A person who is vitamin D deficient absorbs iron less efficiently, which means the iron supplementation that GLOW makes necessary becomes less effective at the same time.

The connection is more consequential here than in a resting context because GLOW creates sustained downward pressure on ferritin. Any additional factor that limits iron uptake compounds that pressure. Low vitamin D and active GLOW use together can produce meaningful iron deficiency in people who would have remained iron-sufficient otherwise.

Vitamin D is fat-soluble, which means it requires a fat-containing meal for proper absorption. The connection to magnesium, covered in the next section, matters here as well: vitamin D supplementation without adequate magnesium cannot be fully converted to its active form, because the enzymatic conversion depends on magnesium as a cofactor.

Synergists That Help Repair Complete

Collagen Peptides

GHK-Cu signals fibroblasts, the cells responsible for building connective tissue, to produce more collagen. This is the mechanism, and it is real and well-studied. But a signal to build is not the same as building. The body still needs the raw materials: glycine, proline, and hydroxyproline, the amino acids that make up collagen protein.

Oral hydrolyzed collagen provides these amino acids in a form the body absorbs efficiently. Human clinical trials in skin elasticity and hydration have established that supplemental collagen peptides increase markers of collagen synthesis. No trial has yet measured the combined effect of injectable peptide signaling alongside oral collagen supplementation. The mechanism is clear and the substrates are real; the magnitude of the combined effect is not yet quantified.

The relationship is complementary rather than redundant: GLOW turns on the gene transcription engine, and collagen peptides ensure the production line has the material to run. Taking collagen peptides alongside vitamin C is worth doing because the collagen modification step that vitamin C enables applies to all collagen synthesis, whether the amino acid substrate came from oral supplements or the body's own reserves.

Omega-3 (EPA and DHA)

Tissue repair is not a single phase. It begins with inflammation, which clears damage and recruits repair cells. Then it must transition to a resolution phase, where inflammation is actively turned off and remodeling begins. The resolution phase is not passive. It requires specific signaling molecules, made from EPA and DHA, that actively tell the body to stand down the inflammatory response and shift into repair mode.

Without adequate EPA and DHA, the resolution phase can be sluggish or incomplete, leaving tissue in a low-grade inflammatory state. The repair process has started but stalled. GLOW is driving the cellular machinery of repair forward, but if the inflammatory environment is not resolving, the remodeling phase it is working toward does not arrive cleanly.

This relationship is supported by controlled trials examining omega-3 supplementation in inflammatory conditions, though the evidence here is mechanistic rather than direct for injectable peptide protocols. The underlying nutritional science is well established.

Magnesium

Magnesium earns its place on this stack through a chain that connects it directly to ferritin, which is GLOW's most important bloodwork marker. The chain runs as follows: magnesium is required for the enzymatic step that converts supplemental vitamin D from its storage form into its active, usable form. Vitamin D in its active form enables iron absorption. GLOW puts sustained downward pressure on iron stores. If magnesium is inadequate, the vitamin D supplementation intended to support iron absorption cannot be converted, and the entire support mechanism for ferritin maintenance breaks down at the first link.

Serum magnesium tests are nearly useless for detecting this problem. The body keeps serum magnesium tightly regulated by pulling from intracellular stores, so serum levels can look normal while functional magnesium status is meaningfully low. RBC magnesium, which measures what is inside red blood cells, reflects intracellular status accurately and is the correct test to order.

Magnesium glycinate is better absorbed and better tolerated than the oxide or sulfate forms. Evening dosing aligns naturally with the recommended evening GLOW injection timing, making it easy to build into a consistent routine.

Curcumin

Curcumin reduces activity in one of the body's central switches for turning on inflammatory gene expression. In plain terms: it helps turn down a persistent inflammation signal. This is valuable in the later phases of tissue repair, when active inflammation should be resolving and the remodeling phase is underway.

The timing caveat here is real and worth taking seriously. In the acute early phase of healing, inflammation is not a problem to be suppressed; it is a necessary part of the process that recruits repair cells and clears damaged tissue. Using a strong anti-inflammatory agent in this window can slow rather than accelerate repair. Curcumin is better deployed in the later remodeling phase of a GLOW cycle, not from the first injection.

The evidence for curcumin as an anti-inflammatory agent in humans is solid, supported by controlled trials in joint and inflammatory conditions. Its specific interaction with GLOW's repair cycle is a mechanistic extension of that evidence rather than a directly studied application.

Curcumin is poorly absorbed without assistance. Formulations that pair it with piperine, the compound in black pepper, or that use phospholipid-based delivery improve bioavailability considerably. Taking it with a fat-containing meal also helps.

Cautions and Interactions

The most important interaction to understand is the zinc-copper relationship, and it is not subtle. High-dose zinc supplementation, at amounts well above the physiological daily range, depletes copper by competing for the same intestinal transport system. Copper is the literal active metal in GHK-Cu, the first peptide in the GLOW blend. The compound delivers copper to activate collagen cross-linking enzymes and antioxidant enzymes. High-dose zinc undermines this by reducing the circulating copper that GHK-Cu needs to work with. Keep zinc at physiological amounts. More zinc is not better on GLOW; above a certain threshold, it is actively counterproductive.

Anyone on anticoagulant medication, including warfarin, should discuss GLOW with a prescribing clinician before starting. BPC-157's role in promoting new blood vessel formation and nitric oxide signaling may interact with anticoagulant therapy in ways that affect bleeding risk. No peptide-specific clinical trial data exists, but the class-level concern is well-founded and warrants medical supervision.

GLOW is contraindicated in the presence of active cancer without explicit oncology clearance. BPC-157 activates the same vascular growth signaling that tumors exploit to build their own blood supply. TB-500 promotes cell motility, which is relevant to how cancer spreads. These are the specific mechanisms that make the compound effective for healing, applied in a context where promoting tissue growth and cell migration are adverse outcomes, not beneficial ones.

The co-supplements recommended with GLOW, including iron, magnesium, and calcium, block levothyroxine absorption when taken at the same time. Anyone taking thyroid medication should separate it from these supplements by at least four hours. The interaction is not with the GLOW peptides themselves but with the support stack around them, and it is easy to overlook.

High-dose NSAIDs, taken regularly at anti-inflammatory doses during a GLOW cycle, work against the compound's mechanism during the acute repair phase. NSAIDs suppress the signaling that is part of how the body initiates and manages the acute inflammatory response that kicks off healing. Occasional use at standard amounts is less concerning than chronic high-dose use through an active cycle.

Vitamin C at pharmacological rather than supplemental levels may theoretically compete with copper bioavailability. At the amounts included in this stack, this is not a meaningful concern. At doses several times higher, the interaction becomes more relevant and would directly conflict with GHK-Cu's copper-delivery mechanism. Standard supplemental amounts are synergistic; pharmacological amounts warrant caution.

Frequently Asked Questions

How much of each supplement should I take with GLOW?

There are no dose numbers in this guide, and that is not an omission. The right amount of each supplement depends on where your ferritin sits, your current vitamin D and copper levels, what else you are taking, and how long you have been running GLOW. A person with low baseline ferritin needs a different iron conversation than someone with normal stores, and the zinc-copper balance has to be managed as a ratio rather than two independent numbers. The MyPeptidePal app takes your protocol, your bloodwork, and your goals and builds a specific plan from those inputs rather than averaging across a population.

Which blood markers should I check when running GLOW?

The most important markers to track are ferritin and a full iron panel, serum copper, and 25-OH-D for vitamin D status. Ferritin can fall during a GLOW cycle through two different mechanisms, and distinguishing between them requires the full iron panel rather than ferritin alone. Serum copper matters because GHK-Cu actively utilizes copper and high-dose zinc can deplete it simultaneously, a combination that can develop quietly without obvious symptoms. RBC magnesium is more informative than serum magnesium for detecting the intracellular deficiency that limits vitamin D activation. Baseline labs before starting and a recheck at around week twelve of a cycle is the standard approach.

Does taking anti-inflammatory supplements like curcumin or omega-3s interfere with how GLOW works?

It depends on timing and the phase of repair. In the acute early phase of tissue healing, some inflammation is necessary and part of the process. Using strong anti-inflammatory agents, curcumin in particular, during this window can slow the repair initiation GLOW is trying to support. Omega-3 fatty acids support the resolution of inflammation rather than simply suppressing it, which makes them a better fit throughout the cycle. Curcumin is better suited to the later remodeling phase, once the initial repair signal has done its job.

Can I skip the support stack and just eat a good diet while running GLOW?

For some people with strong baseline nutrition, a nutrient-dense diet covers enough of the bases that supplementation is less critical. But the specific demands GLOW creates, particularly the active consumption of iron during tissue remodeling and the copper utilization by GHK-Cu, are harder to meet from food alone when the compound is running at full cycle. Vitamin C from food is achievable. Consistently maintaining iron levels when ferritin is actively falling is harder, especially for menstruating women and anyone with a high activity load. Bloodwork tells you more than dietary assumptions do. Know your ferritin before deciding you do not need iron.

Do I need to keep taking these supplements after I finish a GLOW cycle?

It depends on what the supplements were correcting. If you were taking iron because GLOW was depleting ferritin, the depletion pressure stops when the cycle stops, and continuing iron indefinitely without confirming ongoing deficiency is not necessary. Vitamin C, magnesium, and omega-3s have general health value and no reason to stop at the end of a cycle. Collagen peptides are worth continuing through the remodeling phase even after the peptide injections end, because tissue remodeling continues for weeks after active treatment concludes.

This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. MyPeptidePal is not a medical provider. Always consult a qualified healthcare professional before starting, modifying, or stopping any health protocol, supplement regimen, or therapeutic intervention.

Sources

The information in this guide is drawn from the MyPeptidePal knowledge base, which brings together published research, clinical data, and documented real-world use of GLOW and the nutrients that support it in one place.